-
Product Insights
NewReflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trials Market Report Overview The Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trial market research report provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top-line data relating to the clinical trials on Reflux Esophagitis and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7),...
-
Sector Analysis
NewCrohn’s Disease Epidemiology Analysis and Forecast to 2032
Crohn’s Disease Epidemiology Report Overview The number of the diagnosed prevalent cases of Crohn’s Disease (CD) in the 8MM was 1,626,752 in 2022. The number of diagnosed prevalent cases is further projected to grow by more than 4% during the forecast period at an AGR of 0.42% till 2032. Crohn’s disease (CD) is a type of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and...
-
Product Insights
Celiac Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Celiac Disease Clinical Trials Market Report Overview The Celiac Disease clinical trial market research report provides an overview of the Celiac Disease Clinical trials scenario. This report provides top-line data relating to the clinical trials on Celiac Disease and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Product Insights
Ulcerative Colitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ulcerative Colitis Clinical Trials Market Report Overview The Ulcerative Colitis clinical trial market research report provides an overview of the Ulcerative Colitis Clinical trials scenario. This report provides top-line data relating to the clinical trials on Ulcerative Colitis and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Sector Analysis
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Report Overview Gastroesophageal Reflux Disease marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for reflux esophagitis (RE)/ gastroesophageal reflux disease (GERD). Gastroesophageal Reflux Disease Marketed Drugs Report Overview Key Mechanisms of Action ·      Enzyme Inhibitor ·      Receptor Agonist ·      Receptor Antagonist...
-
Sector Analysis
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Report Overview Short bowel syndrome (SBS) is defined as a condition in which poor absorption of required nutrients from foods occurs due to a lack of sufficient length of the small intestine. SBS usually occurs when portions of the small intestine have been surgically removed due to various underlying conditions like inflammatory bowel disease (IBD), cancer, traumatic injuries, and blood clots in the arteries that supply blood to the intestine. In rare...
-
Product Insights
Inflammatory Bowel Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Inflammatory Bowel Disease Clinical Trials Market Report Overview The Inflammatory Bowel Disease clinical trial market research report provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. The report also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
Ulcerative Colitis Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast to 2031
Ulcerative Colitis Market Overview The ulcerative colitis (UC) market size across the 8MM was valued at $7.3 billion in 2021 and is expected to achieve a CAGR of more than 2% during 2021-2031. The symptoms of UC vary from person to person and may include diarrhea with blood or pus, passing blood with stool, abdominal pain & cramping, and tenesmus or urgency to defecate. UC can occur at any age, although most people are diagnosed in their mid-thirties. Men and...
-
Thematic Analysis
Digital Marketing Trends in Inflammatory Bowel Disease
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 9.3 million visitors from March 2022 to February 2023. This was followed by AbbVie’s Rinvoq.com and Takeda’s Entyvio.com. The highest proportion of traffic originated from direct sources, followed by organic. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Takeda spent on digital display advertising (DDA) for Entyvio.com. The digital marketing...
-
Product Insights
Zollinger-Ellison Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Zollinger-Ellison Syndrome Clinical Trials Market Report Overview The Zollinger-Ellison Syndrome clinical trial market research report provides an overview of the Zollinger-Ellison Syndrome clinical trials scenario. The report provides top-line data relating to the clinical trials on Zollinger-Ellison Syndrome. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Non-Alcoholic Steatohepatitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trials Market Report Overview The Non-Alcoholic Steatohepatitis (NASH) clinical trial market research report provides an overview of the NASH clinical trials scenario. The report provides top-line data relating to the clinical trials on NASH. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Ulcerative Colitis Epidemiology Analysis and Forecast to 2031
Ulcerative Colitis Market Report Overview In the 8MM, there were 1,946,428 diagnosed prevalent cases of Ulcerative Colitis (UC) in 2021. The cases are expected to achieve an AGR of less than 1% during the period 2021-2031. Of the 8MM, Canada is expected to have the highest increase in the number of diagnosed prevalent cases of UC by 2031, and Italy will have the lowest increase in the number of diagnosed prevalent cases. Any change in the diagnosed prevalent cases of...
-
Product Insights
Gastric Ulcers Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gastric Ulcers Clinical Trials Market Report Overview The Gastric Ulcers clinical trial market research report provides an overview of the Gastric Ulcers clinical trials scenario. The report provides top-line data relating to the clinical trials on Gastric Ulcers. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Liver Fibrosis Clinical Trials Market Report Overview The liver fibrosis clinical trial market research report provides an overview of the liver fibrosis clinical trial scenario. The report provides top-line data relating to the clinical trials on liver fibrosis. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Non-Alcoholic Fatty Liver Disease (NAFLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non Alcoholic Fatty Liver Pipeline Drugs Analysis Overview Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis when no other causes for secondary hepatic fat accumulation (such as excessive alcohol consumption) can be identified. NAFLD ranges from the more benign condition of non-alcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), which is at the more severe end of the spectrum. The NAFLD marketed and pipeline drugs market research report provides a data-driven overview of the...
-
Product Insights
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
NAFLD Clinical Trials Market Report Overview The NAFLD clinical trial market research report provides an overview of the NAFLD clinical trials scenario. The report provides top-line data relating to the clinical trials on NAFLD. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Liver Failure (Hepatic Insufficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, a tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea, and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure...
-
Product Insights
Short Bowel Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness, and diarrhea. Complications of short bowel syndrome include malnutrition, peptic ulcers, kidney stones, and small intestinal bacterial overgrowth. Treatment includes vitamin and mineral supplements, antibiotics, proton pump inhibitors, and bile-salt binders The Short Bowel Syndrome pipeline drugs market research report provides comprehensive information on...
-
Product Insights
Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peptic Ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target,...
-
Product Insights
Liver Failure (Hepatic Insufficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Liver Failure clinical trial market research report provides an overview of the Liver Failure (Hepatic Insufficiency) clinical trials scenario and top-line data relating to the clinical trials on Liver Failure (Hepatic Insufficiency). It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.